1.
Aberer E, Neumann R, Stanek G. Is localised scleroderma a Borrelia infection?
Lancet. 1985; 326(8449) : 278
2.
Raguin G,
Boisnic S,
Souteyrand P,
Baranton G,
Piette JC,
Godeau P,
et al.
No evidence for a spirochaetal origin of localized scleroderma.
Br J Dermatol. 1992; 127(3) : 218
-20
[PubMed]
3.
Ross SA, Sanchez JL, Taboas JO. Spirochetal forms in the dermal lesions of morphea and lichen sclerosus et atrophicus.
Am J Dermatopathol. 1990; 12(4) : 357
-62
[PubMed]
4.
Weber K, Preac-Mursic V, Reimers CD. Spirochetes isolated from two patients with morphea.
Infection. 1988; 16(1) : 25
-6
[PubMed]
5.
Weide B,
Schittek B,
Klyscz T,
Schuz K,
Stark M,
Rassner G,
et al.
Morphoea is neither associated with features of Borrelia burgdorferi infection, nor is this agent detectable in lesional skin by polymerase chain reaction.
Br J Dermatol. 2000; 143(4) : 780
-5
[PubMed]
6.
Ranki A, Aavik E, Peterson P, Schauman K, Nurmilaakso P. Successful amplification of DNA specific for Finnish Borrelia burgdorferi isolates in erythema chronicum migrans but not in circumscribed scleroderma lesions.
J Invest Dermatol. 1994; 102(3) : 339
-45
[PubMed]
7.
Wienecke R, Schlupen EM, Zochling N, Neubert U, Meurer M, Volkenandt M. No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma.
J Invest Dermatol. 1995; 104(1) : 23
-6
[PubMed]
8.
Schempp C, Bocklage H, Lange R, Kolmel HW, Orfanos CE, Gollnick H. Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification.
J Invest Dermatol. 1993; 100(5) : 717
-20
[PubMed]
9.
De Vito JR,
Merogi AJ,
Vo T,
Boh EE,
Fung HK,
Freeman SM,
et al.
Role of Borrelia burgdorferi in the pathogenesis of morphea/scleroderma and lichen sclerosus et atrophicus: a PCR study of thirty-five cases.
J Cutan Pathol. 1996; 23(4) : 350
-8
[PubMed]
10.
Fujiwara H,
Fujiwara K,
Hashimoto K,
Mehregan AH,
Schaumburg-Lever G,
Lange R,
et al.
Detection of Borrelia burgdorferi DNA (B garinii or B afzelii) in morphea and lichen sclerosus et atrophicus tissues of German and Japanese but not of US patients.
Arch Dermatol. 1997; 133(1) : 41
-4
[PubMed]
11.
Dillon WI, Saed GM, Fivenson DP. Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America.
J Am Acad Dermatol. 1995; 33(4) : 617
-20
[PubMed]
12.
Fan W, Leonardi CL, Penneys NS. Absence of Borrelia burgdorferi in patients with localized scleroderma (morphea).
J Am Acad Dermatol. 1995; 33(4) : 682
-4
[PubMed]
13.
Colome-Grimmer MI, Payne DA, Tyring SK, Sanchez RL. Borrelia burgdorferi DNA and Borrelia hermsii DNA are not associated with morphea or lichen sclerosus et atrophicus in the southwestern United States.
Arch Dermatol. 1997; 133(9) : 1174
14.
Vynograd N, Komarenko N. Molecular-genetic typing of Borrelia circulating in Kyiv Oblast.
Ann Acad Med Siles. 2013; 67(6) : 380
-3
15.
Kwok S, Higuchi R. Avoiding false positives with PCR.
Nature. 1989; 339(6221) : 237
-8
[DOI][PubMed]
16.
Classification of morphea (localized scleroderma).
Mayo Clinic Proceedings. : 1068
-76
17.
Lupoli S, Cutler SJ, Stephens CO, Wright DJ, Black CM. Lyme disease and localized scleroderma--no evidence for a common aetiology.
Br J Rheumatol. 1991; 30(2) : 154
-6
[PubMed]
18.
Meis JF, Koopman R, van Bergen B, Pool G, Melchers W. No evidence for a relation between Borrelia burgdorferi infection and old lesions of localized scleroderma (morphea).
Arch Dermatol. 1993; 129(3) : 386
-7
19.
Daoud MS, Su WP, Leiferman KM, Perniciaro C. Bullous morphea: clinical, pathologic, and immunopathologic evaluation of thirteen cases.
J Am Acad Dermatol. 1994; 30(6) : 937
-43
[PubMed]
20.
Aberer E, Stanek G, Ertl M, Neumann R. Evidence for spirochetal origin of circumscribed scleroderma (morphea).
Acta Derm Venereol. 1987; 67(3) : 225
-31
[PubMed]
21.
Aberer E, Kollegger H, Kristoferitsch W, Stanek G. Neuroborreliosis in morphea and lichen sclerosus et atrophicus.
J Am Acad Dermatol. 1988; 19(5 Pt 1) : 820
-5
[PubMed]
22.
Aberer E, Klade H, Stanek G, Gebhart W. Borrelia burgdorferi and different types of morphea.
Dermatologica. 1991; 182(3) : 145
-54
[PubMed]
23.
Aberer E, Stanek G. Histological evidence for spirochetal origin of morphea and lichen sclerosus et atrophicans.
Am J Dermatopathol. 1987; 9(5) : 374
-9
[PubMed]
24.
Breier P,
Klade H,
Stanek G,
Poitschek C,
Kirnbauer R,
Dorda W,
et al.
Lymphoproliferative responses to Borrelia burgdorferi in circumscribed scleroderma.
Br J Dermatol. 1996; 134(2) : 285
-91
[PubMed]
25.
Alonso-Llamazares J, Persing DH, Anda P, Gibson LE, Rutledge BJ, Iglesias L. No evidence for Borrelia burgdorferi infection in lesions of morphea and lichen sclerosus et atrophicus in Spain. A prospective study and literature review.
Acta Derm Venereol. 1997; 77(4) : 299
-304
[PubMed]
26.
Trevisan G, Stinco G, Nobile C, Bonin S, Stanta G. Detection of Borrelia burgdorferi in skin biopsies from patients with morphea by polymerase chain reaction.
J Eur Acad Dermatol Venereol. 1996; 6(1) : 15
-9
27.
Aberer E, Kersten A, Klade H, Poitschek C, Jurecka W. Heterogeneity of Borrelia burgdorferi in the skin.
Am J Dermatopathol. 1996; 18(6) : 571
-9
28.
Breier FH, Aberer E, Stanek G, Khanakaha G, Schlick A, Tappeiner G. Isolation of Borrelia afzelii from circumscribed scleroderma.
Br J Dermatol. 1999; 140(5) : 925
-30
29.
Eisendle K, Grabner T, Zelger B. Morphoea: a manifestation of infection with Borrelia species?
Br J Dermatol. 2007; 157(6) : 1189
-98
[DOI][PubMed]
30.
Ozkan S, Atabey N, Fetil E, Erkizan V, Gunes AT. Evidence for Borrelia burgdorferi in morphea and lichen sclerosus.
Int J Dermatol. 2000; 39(4) : 278
-83
[PubMed]
31.
Goodlad JR, Davidson MM, Gordon P, Billington R, Ho-Yen DO. Morphoea and Borrelia burgdorferi: results from the Scottish Highlands in the context of the world literature.
Mol Pathol. 2002; 55(6) : 374
-8
[PubMed]
LEAVE A COMMENT HERE: